BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fasoulakis Z, Kolios G, Papamanolis V, Kontomanolis EN. Interleukins Associated with Breast Cancer. Cureus 2018;10:e3549. [PMID: 30648081 DOI: 10.7759/cureus.3549] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Khan A, Rehman Z, Hashmi HF, Khan AA, Junaid M, Sayaf AM, Ali SS, Hassan FU, Heng W, Wei D. An Integrated Systems Biology and Network-Based Approaches to Identify Novel Biomarkers in Breast Cancer Cell Lines Using Gene Expression Data. Interdiscip Sci Comput Life Sci 2020;12:155-68. [DOI: 10.1007/s12539-020-00360-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
2 Radziejewska I, Borzym-Kluczyk M, Leszczyńska K. Luteolin alters MUC1 extracellular domain, sT antigen, ADAM-17, IL-8, IL-10 and NF-κB expression in Helicobacter pylori-infected gastric cancer CRL-1739 cells: A preliminary study. Biomed Rep 2021;14:19. [PMID: 33335725 DOI: 10.3892/br.2020.1395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Murugan S, Rousseau B, Sarkar DK. Beta 2 Adrenergic Receptor Antagonist Propranolol and Opioidergic Receptor Antagonist Naltrexone Produce Synergistic Effects on Breast Cancer Growth Prevention by Acting on Cancer Cells and Immune Environment in a Preclinical Model of Breast Cancer. Cancers (Basel) 2021;13:4858. [PMID: 34638341 DOI: 10.3390/cancers13194858] [Reference Citation Analysis]
4 Calaf GM, Crispin LA, Roy D, Aguayo F, Muñoz JP, Bleak TC. Gene Signatures Induced by Ionizing Radiation as Prognostic Tools in an In Vitro Experimental Breast Cancer Model. Cancers (Basel) 2021;13:4571. [PMID: 34572798 DOI: 10.3390/cancers13184571] [Reference Citation Analysis]
5 Mu X, Zhao Q, Chen W, Zhao Y, Yan Q, Peng R, Zhu J, Yang C, Lan K, Gu X, Wang Y. IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation. Front Oncol 2020;10:526866. [PMID: 33489865 DOI: 10.3389/fonc.2020.526866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Naik A, Thomas R, Al-Khadairi G, Bacha R, Hendrickx W, Decock J. Cancer testis antigen PRAME: An anti-cancer target with immunomodulatory potential. J Cell Mol Med 2021;25:10376-88. [PMID: 34612587 DOI: 10.1111/jcmm.16967] [Reference Citation Analysis]
7 Stakheyeva M, Patysheva M, Kaigorodova E, Zavyalova M, Tarabanovskaya N, Choynzonov E, Cherdyntseva N. Tumor Properties Mediate the Relationship Between Peripheral Blood Monocytes and Tumor-Associated Macrophages in Breast Cancer. Cancer Invest 2021;:1-20. [PMID: 34882039 DOI: 10.1080/07357907.2021.2016803] [Reference Citation Analysis]
8 Xi C, Zhang GQ, Sun ZK, Song HJ, Shen CT, Chen XY, Sun JW, Qiu ZL, Luo QY. Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice. Front Immunol 2020;11:1124. [PMID: 32655554 DOI: 10.3389/fimmu.2020.01124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Arana Echarri A, Beresford M, Campbell JP, Jones RH, Butler R, Gollob KJ, Brum PC, Thompson D, Turner JE. A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling. Front Immunol 2020;11:616188. [PMID: 33597950 DOI: 10.3389/fimmu.2020.616188] [Reference Citation Analysis]
10 Eyermann CE, Li J, Alexandrova EM. ΔN63 suppresses the ability of pregnancy-identified mammary epithelial cells (PIMECs) to drive HER2-positive breast cancer. Cell Death Dis 2021;12:525. [PMID: 34023861 DOI: 10.1038/s41419-021-03795-5] [Reference Citation Analysis]
11 Pratiwi R, Antara NY, Fadliansyah LG, Ardiansyah SA, Nurhidayat L, Sholikhah EN, Sunarti S, Widyarini S, Fadhlurrahman AG, Fatmasari H, Tunjung WAS, Haryana SM, Alamsyah F, Taruno WP. CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo. F1000Res 2019;8:1770. [PMID: 32695310 DOI: 10.12688/f1000research.20727.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Choi HG, Suh YJ, Lee JW, Min CY, Yoo DM, Lee SW. Analyses of the association between breast cancer and osteoporosis/fracture history: a cross-sectional study using KoGES HEXA data. Arch Osteoporos 2021;16:98. [PMID: 34148148 DOI: 10.1007/s11657-021-00947-0] [Reference Citation Analysis]
13 Chu DT, Phuong TNT, Tien NLB, Tran DK, Nguyen TT, Thanh VV, Quang TL, Minh LB, Pham VH, Ngoc VTN, Kushekhar K, Chu-Dinh T. The Effects of Adipocytes on the Regulation of Breast Cancer in the Tumor Microenvironment: An Update. Cells 2019;8:E857. [PMID: 31398937 DOI: 10.3390/cells8080857] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
14 Dashti S, Taheri M, Ghafouri-Fard S. An in-silico method leads to recognition of hub genes and crucial pathways in survival of patients with breast cancer. Sci Rep 2020;10:18770. [PMID: 33128008 DOI: 10.1038/s41598-020-76024-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Gonçalves Dos Santos G, Delay L, Yaksh TL, Corr M. Neuraxial Cytokines in Pain States. Front Immunol 2019;10:3061. [PMID: 32047493 DOI: 10.3389/fimmu.2019.03061] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]